Tenaya Therapeutics, Inc.
TNYA
$0.4912
$0.03066.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.01% | 12.90% | 8.68% | -7.66% | -2.72% |
| Total Depreciation and Amortization | -0.57% | -1.04% | -1.48% | -1.19% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.35% | -10.94% | 11.44% | -22.29% | 42.94% |
| Change in Net Operating Assets | 21.34% | 32.08% | 46.72% | -442.32% | 45.18% |
| Cash from Operations | 7.30% | 16.01% | 17.60% | -30.72% | 7.25% |
| Capital Expenditure | -10.87% | -152.05% | 87.06% | -43.15% | -4,825.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 147.83% | -237.93% | 652.56% | 72.98% | -147.63% |
| Cash from Investing | 146.86% | -239.25% | 581.51% | 69.91% | -148.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,116.13% | -94.56% | -98.78% | 12,506.74% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,116.13% | -94.56% | -98.78% | 12,506.74% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.17% | -3,384.85% | -110.51% | 137.35% | -632.44% |